Pyxis Oncology EPS PYXS

Diluted earnings per share by quarter and over the last twelve months, from 2020.

Pyxis Oncology's earnings per share was −$1.41 over the twelve months to Jun 30, 2026.

In its latest quarter, Q2 FY26, it was −$0.40.

Earnings per share over time

Each fiscal year is the twelve months to its fourth quarter.

Quarter	Ended	EPS	On a year earlier	Last 12 months
Q2 FY26	Jun 30, 2026	−$0.40	n/a	−$1.41
Q1 FY26	Mar 31, 2026	−$0.37	n/a	−$1.31
Q4 FY25	Dec 31, 2025	−$0.29	n/a	−$1.29
Q3 FY25	Sep 30, 2025	−$0.35	n/a	−$1.58
Q2 FY25	Jun 30, 2025	−$0.30	n/a	−$1.58
Q1 FY25	Mar 31, 2025	−$0.35	n/a	−$1.57
Q4 FY24	Dec 31, 2024	−$0.58	n/a	−$1.28
Q3 FY24	Sep 30, 2024	−$0.35	n/a	−$1.05
Q2 FY24	Jun 30, 2024	−$0.29	n/a	−$1.26
Q1 FY24	Mar 31, 2024	−$0.06	n/a	−$1.38
Q4 FY23	Dec 31, 2023	−$0.35	n/a	−$1.86
Q3 FY23	Sep 30, 2023	−$0.56	n/a	−$2.55

Companies in Drug Manufacturers - General nearest Pyxis Oncology's size, closest first, today.

Company	EPS, 12 months	Growth
PYXSPyxis Oncology	−$1.41
NATRNatures Sunshine Products	$1.01	+36% a year
LFVNLifevantage	$0.40	−46% a year
SPROSpero Therapeutics	$0.11
ATNMActinium Pharmaceuticals	$0.36
ARVNArvinas	$0.16
PBYIPuma Biotechnology	$0.52	−47% a year
IRWDIronwood Pharmaceuticals	$0.77
ZVRAZevra Therapeutics	$0.93
CRMDCorMedix	$2.13	+184% a year
COLLCollegium Pharmaceutical	$1.24	+19% a year
Peer median	$0.65